FyMed-301

N/A

Report date: 2025/03/20 15:39:07
NME

Base Information

Drug NameFyMed-301
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFymed
China Registration ClassN/A

Develop Information

Active CompaniesFymed
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A